The FDA has linked a fungal meningitis outbreak to potentially contaminated methylprednisolone acetate from NECC, though the exact source of the outbreak is still ongoing.
However, the FDA has observed fungal contamination from a sealed vial of the injectable steroid produced and distributed by NECC and is conducting additional testing to confirm the exact species of fungus.
As a precaution, governmental officials recommend discontinuing use of all NECC products while retaining and securing all remaining products purchased from NECC until the FDA provides instructions on disposal.
More Articles on Anesthesia:
Somnia Anesthesia to Offer Webinar on Anesthesia Career Trends
CBIZ Acquires Anesthesia Billing Company ProMedical
Physician Lawmakers Concerned by Policy to Allow Patients to Report Medical Mistakes
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
